SCHEMBL19741672

SCHEMBL19741672

CC(C)CC(CO)NC(C)c1cc(C(=O)O)ccn1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4D Q6B0I6 3/20 0.45
▸ KDM4C Q9H3R0 6/20 0.39
▸ KDM4E B2RXH2 5/20 0.39
▸ KDM5C P41229 4/20 0.39
▸ KDM6B O15054 3/20 0.39
▸ KDM2A Q9Y2K7 3/20 0.39
▸ KDM3A Q9Y4C1 3/20 0.39
▸ KDM5A P29375 6/20 0.39
▸ KDM5B Q9UGL1 6/20 0.39
▸ KDM4A O75164 2/20 0.39
▸ TET3 O43151 1/20 0.39
▸ BBOX1 O75936 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ ASPH Q12797 1/20 0.39
▸ TET2 Q6N021 1/20 0.39
▸ ALKBH5 Q6P6C2 1/20 0.39
▸ KDM7A Q6ZMT4 1/20 0.39
▸ KDM8 Q8N371 1/20 0.39
▸ TET1 Q8NFU7 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17144445 1.00 KDM4D (0.45) KDM4DKDM4CKDM4EKDM5CKDM6B
SCHEMBL17144520 0.77 TRPV3 (0.50) KDM4DKDM4CKDM4EKDM5CKDM6B
SCHEMBL17144518 0.77 TRPV3 (0.50) KDM4DKDM4CKDM4EKDM5CKDM6B
SCHEMBL19741728 0.72 KDM5B (0.42) KDM4DKDM4CKDM4EKDM5CKDM6B
SCHEMBL1759894 0.72 KDM4C (0.55) KDM4DKDM4CKDM4EKDM5CKDM6B
SCHEMBL19741717 0.72 MAPKAPK2 (0.40) KDM4DKDM4CKDM4EKDM5CKDM6B
SCHEMBL19741706 0.72 MAPKAPK2 (0.40) KDM4DKDM4CKDM4EKDM5CKDM6B
SCHEMBL17144356 0.72 MAPKAPK2 (0.40) KDM4DKDM4CKDM4EKDM5CKDM6B
SCHEMBL19741698 0.72 KMT2A (0.37) KDM4DKDM4CKDM4EKDM5CKDM6B
SCHEMBL19741696 0.72 KMT2A (0.37) KDM4DKDM4CKDM4EKDM5CKDM6B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170369444-A1 INHIBITORS OF HISTONE DEMETHYLASES EPITHERAPEUTICS APS (DK) 2017-12-28 — — US claimed
US-20170369444-A1 INHIBITORS OF HISTONE DEMETHYLASES EPITHERAPEUTICS APS (DK) 2017-12-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170369444-A1 INHIBITORS OF HISTONE DEMETHYLASES KDM1B, KDM3A, KDM1A KDM4D 53/4885KDM4C 38/4885KDM4E 17/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback